People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synchrony Inc | — | Other Technology | Series A | $20.0M | $138.7M | 2009 |
| Chorda Pharma, Inc. | — | Pharmaceuticals | Pre-Seed | $493K | $703K | 2021 |
Victor Iannello at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Victor Iannello on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Williamson | 1 | 10 |
| Matthew Crisp | 1 | 3 |
| Scott Horner | 1 | 3 |
| James Turk | 1 | 2 |
| Daniel Sable | 1 | 2 |
| Robert Vaughn | 1 | 1 |
| Troy Keyser | 1 | 1 |
| Troy Jamison | 1 | 1 |
| Ted Melnik | 1 | 1 |
| Carl Hoffman | 1 | 1 |
| Brian Mackey | 1 | 1 |
| Art Claybon | 1 | 1 |
| George Robert Vaughan, Jr. | 1 | 1 |
| Aileen B Helsel | 1 | 1 |
| Richard Carliss | 1 | 1 |
| John B Williamson III | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.